Učitavanje...
Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial
BACKGROUND: As genetic tests become cheaper, the possibility of their widespread availability must be considered. This study involves a risk score for lung cancer in smokers that is roughly 50% genetic (50% clinical criteria). The risk score has been shown to be effective as a smoking cessation moti...
Spremljeno u:
| Izdano u: | BMC Res Notes |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653992/ https://ncbi.nlm.nih.gov/pubmed/29061161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2831-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|